Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02670499 · ClinicalTrials.gov registry record · NA
Study Comparing GAP-Flex to CPM Therapy in Treatment of TKR
A NA study of Total Knee Replacement, sponsored by Xeras Medical Technologies.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT02670499: Completed NA study of Total Knee Replacement, sponsored by Xeras Medical Technologies.
NCT02670499 is a NA study of Total Knee Replacement that has completed, run by Xeras Medical Technologies. The registered enrollment target is 28 participants, below the 213-participant average among 9 other Total Knee Replacement trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02670499, a NA study of Total Knee Replacement, has completed, sponsored by Xeras Medical Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
Post Market TKR study
Primary Outcome
improvement in week 4 visit degree of flexion measured by Goniometer in the GAP-FLEX group will be compared to the CPM
Conditions Studied
Interventions
- DEVICE CPM
- DEVICE GAPFLEX
Study Locations (2)
Texas
- Nix Orthopaedic Center - San Antonio
- Orthopaedic Institute - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-11-18 |
| Est. Completion | 2017-06-23 |
| Phase | NA |
What the finished NCT02670499 record still lists
NCT02670499 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 213-participant average among 9 other Total Knee Replacement trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Total Knee Replacement appearing as the primary indexed condition, and to 2 interventions - of which CPM is the first listed.
NCT02670499 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02670499 about?
NCT02670499 is a clinical study titled "Study Comparing GAP-Flex to CPM Therapy in Treatment of TKR". Post Market TKR study
What is the current status of trial NCT02670499?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-11-18. Estimated completion is 2017-06-23.
What conditions does trial NCT02670499 study?
This clinical trial studies the following conditions: Total Knee Replacement.
What interventions are being tested in trial NCT02670499?
The interventions under investigation include: CPM (DEVICE), GAPFLEX (DEVICE).
Who is sponsoring clinical trial NCT02670499?
This trial is sponsored by Xeras Medical Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02670499 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Replacement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02670499's enrollment target sits among peer trials
28 10th of 9 the lowest of 9 other Total Knee Replacement trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Total Knee Replacement trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Knee Arthroplasty Activity Trial
ACTIVE NOT RECRUITING · NA
-
X-3 Polyethylene Survival Outcomes Study
COMPLETED · NA
-
Mindfulness Meditation Intervention Study
COMPLETED · NA
-
Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study
RECRUITING · Phase 2
-
An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool
RECRUITING
-
Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI